Current molecular studies have furnished several insights into the processes that govern the event and progression of CLL, which include a lot of novel mutated genes clustered in several purposeful pathways. The CLL epigenome is reprogrammed from the modulation of regulatory areas that seem de novo during the disease, While other areas maintain fun